ALDR
Bank of New York Mellon’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-300,507
| Closed | -$5.67M | – | 4298 |
|
|
2019
Q3 | $5.67M | Buy |
300,507
+12,047
| +4% | +$227K | ﹤0.01% | 2220 |
|
|
2019
Q2 | $3.4M | Buy |
288,460
+23,286
| +9% | +$274K | ﹤0.01% | 2520 |
|
|
2019
Q1 | $3.62M | Sell |
265,174
-64
| -0% | -$873 | ﹤0.01% | 2487 |
|
|
2018
Q4 | $2.72M | Sell |
265,238
-1,351
| -0.5% | -$13.8K | ﹤0.01% | 2590 |
|
|
2018
Q3 | $4.44M | Sell |
266,589
-6,271
| -2% | -$104K | ﹤0.01% | 2461 |
|
|
2018
Q2 | $4.31M | Sell |
272,860
-37,055
| -12% | -$585K | ﹤0.01% | 2472 |
|
|
2018
Q1 | $3.94M | Sell |
309,915
-10,114
| -3% | -$128K | ﹤0.01% | 2471 |
|
|
2017
Q4 | $3.66M | Buy |
320,029
+4,873
| +2% | +$55.8K | ﹤0.01% | 2496 |
|
|
2017
Q3 | $3.86M | Buy |
315,156
+82,869
| +36% | +$1.01M | ﹤0.01% | 2465 |
|
|
2017
Q2 | $2.66M | Buy |
232,287
+21,886
| +10% | +$251K | ﹤0.01% | 2675 |
|
|
2017
Q1 | $4.38M | Buy |
210,401
+9,218
| +5% | +$192K | ﹤0.01% | 2392 |
|
|
2016
Q4 | $4.19M | Sell |
201,183
-10,218
| -5% | -$213K | ﹤0.01% | 2421 |
|
|
2016
Q3 | $6.93M | Buy |
211,401
+13,633
| +7% | +$447K | ﹤0.01% | 2073 |
|
|
2016
Q2 | $4.94M | Buy |
197,768
+91,328
| +86% | +$2.28M | ﹤0.01% | 2216 |
|
|
2016
Q1 | $2.61M | Sell |
106,440
-16,611
| -13% | -$407K | ﹤0.01% | 2516 |
|
|
2015
Q4 | $4.07M | Buy |
123,051
+2,900
| +2% | +$95.8K | ﹤0.01% | 2336 |
|
|
2015
Q3 | $3.94M | Sell |
120,151
-2,704
| -2% | -$88.6K | ﹤0.01% | 2358 |
|
|
2015
Q2 | $6.51M | Buy |
122,855
+58,349
| +90% | +$3.09M | ﹤0.01% | 2197 |
|
|
2015
Q1 | $1.86M | Buy |
64,506
+16,240
| +34% | +$469K | ﹤0.01% | 2925 |
|
|
2014
Q4 | $1.4M | Buy |
48,266
+7,794
| +19% | +$227K | ﹤0.01% | 3093 |
|
|
2014
Q3 | $512K | Buy |
40,472
+1,988
| +5% | +$25.2K | ﹤0.01% | 3611 |
|
|
2014
Q2 | $773K | Buy |
+38,484
| New | +$773K | ﹤0.01% | 3446 |
|